FITZGERALD KEVIN JOSEPH (CSO & EVP, Head of Research) sold 5.9% of their position (1.29K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $417.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−29.00
Price / share
$319.03
Trade value
$9.25K
% of position
Common Stock
Shares
−28.00
Price / share
$320.01
Trade value
$8.96K
% of position
Common Stock
Shares
−59.00
Price / share
$320.81
Trade value
$18.93K
% of position
Common Stock
Shares
−79.00
Price / share
$321.82
Trade value
$25.42K
% of position
Common Stock
Shares
−96.00
Price / share
$323.01
Trade value
$31.01K
% of position
Common Stock
Shares
−210.00
Price / share
$323.84
Trade value
$68.01K
% of position
Common Stock
Shares
−75.00
Price / share
$324.88
Trade value
$24.37K
% of position
Common Stock
Shares
−57.00
Price / share
$325.67
Trade value
$18.56K
% of position
Common Stock
Shares
−124.00
Price / share
$321.81
Trade value
$39.90K
% of position
Common Stock
Shares
−233.00
Price / share
$323.25
Trade value
$75.32K
% of position
Common Stock
Shares
−148.00
Price / share
$324.60
Trade value
$48.04K
% of position
Common Stock
Shares
−153.00
Price / share
$326.24
Trade value
$49.91K
% of position
Net shares
−1.29K
Net value
-$417.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | S · Sale | −29.00 | $319.03 | $9.25K | 0.1% | 21.86K | 21.83K |
| Common Stock Direct | 3/4/2026 | S · Sale | −28.00 | $320.01 | $8.96K | 0.1% | 21.83K | 21.80K |
| Common Stock Direct | 3/4/2026 | S · Sale | −59.00 | $320.81 | $18.93K | 0.3% | 21.80K | 21.74K |
| Common Stock Direct | 3/4/2026 | S · Sale | −79.00 | $321.82 | $25.42K | 0.4% | 21.74K | 21.66K |
| Common Stock Direct | 3/4/2026 | S · Sale | −96.00 | $323.01 | $31.01K | 0.4% | 21.66K | 21.57K |
| Common Stock Direct | 3/4/2026 | S · Sale | −210.00 | $323.84 | $68.01K | 1.0% | 21.57K | 21.36K |
| Common Stock Direct | 3/4/2026 | S · Sale | −75.00 | $324.88 | $24.37K | 0.4% | 21.36K | 21.28K |
| Common Stock Direct | 3/4/2026 | S · Sale | −57.00 | $325.67 | $18.56K | 0.3% | 21.28K | 21.23K |
| Common Stock Direct | 3/5/2026 | S · Sale | −124.00 | $321.81 | $39.90K | 0.6% | 21.23K | 21.10K |
| Common Stock Direct | 3/5/2026 | S · Sale | −233.00 | $323.25 | $75.32K | 1.1% | 21.10K | 20.87K |
| Common Stock Direct | 3/5/2026 | S · Sale | −148.00 | $324.60 | $48.04K | 0.7% | 20.87K | 20.72K |
| Common Stock Direct | 3/5/2026 | S · Sale | −153.00 | $326.24 | $49.91K | 0.7% | 20.72K | 20.57K |
| Total | −1.29K | -$417.69K | ||||||
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 537.00 | Indirect |
| Total | 537.00 | 537.00 indirect |